Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer
出版年份 2019 全文链接
标题
Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer
作者
关键词
Head and neck squamous cell cancer (HNSCC), Immune checkpoint blockade, Tumor infiltrating lymphocytes (TILs), T cells, PD-L1
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 68, Issue 9, Pages 1443-1454
出版商
Springer Science and Business Media LLC
发表日期
2019-08-24
DOI
10.1007/s00262-019-02378-w
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
- (2018) Ranee Mehra et al. BRITISH JOURNAL OF CANCER
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
- (2018) Carsten Denkert et al. LANCET ONCOLOGY
- Properdin: A multifaceted molecule involved in inflammation and diseases
- (2018) Jin Y. Chen et al. MOLECULAR IMMUNOLOGY
- Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
- (2018) Robert L. Ferris et al. ORAL ONCOLOGY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- New developments in the management of head and neck cancer – impact of pembrolizumab
- (2018) Khalil Saleh et al. Therapeutics and Clinical Risk Management
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis
- (2018) Wei-fa Yang et al. ORAL ONCOLOGY
- Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
- (2018) M Oliva et al. ANNALS OF ONCOLOGY
- Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
- (2018) Dan P. Zandberg et al. EUROPEAN JOURNAL OF CANCER
- Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
- (2018) Ezra E W Cohen et al. LANCET
- Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis
- (2017) Ji Li et al. PLoS One
- Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Head and Neck Squamous Cell Carcinoma
- (2017) Qiaoshi Xu et al. Translational Oncology
- Epacadostat Shows Value in Two SCCHN Trials
- (2017) Cancer Discovery
- PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
- (2017) Tim Müller et al. Oncotarget
- The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis
- (2017) Emma J. de Ruiter et al. OncoImmunology
- Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
- (2017) Sacha Gnjatic et al. Journal for ImmunoTherapy of Cancer
- Current status of systemic therapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck
- (2016) T Chaudhuri et al. INDIAN JOURNAL OF CANCER
- Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
- (2016) Tanguy Y Seiwert et al. LANCET ONCOLOGY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer
- (2016) Yu Lei et al. ORAL ONCOLOGY
- Current status of systemic therapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck
- (2016) T Chaudhuri et al. INDIAN JOURNAL OF CANCER
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma
- (2015) M. Vassilakopoulou et al. CLINICAL CANCER RESEARCH
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Epidemiology of Head and Neck Cancer
- (2015) Eleni M. Rettig et al. Surgical Oncology Clinics of North America
- Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
- (2015) Simona Partlová et al. OncoImmunology
- An updated overview of HPV-associated head and neck carcinomas
- (2015) Apostolos Zaravinos Oncotarget
- Epidemiologic Trends in Head and Neck Cancer and Aids in Diagnosis
- (2014) Nadarajah Vigneswaran et al. Oral and Maxillofacial Surgery Clinics of North America
- Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
- (2013) M J Ward et al. BRITISH JOURNAL OF CANCER
- CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma
- (2013) Cecilia Nordfors et al. EUROPEAN JOURNAL OF CANCER
- Tumor Infiltrating CD8+ and Foxp3+ Lymphocytes Correlate to Clinical Outcome and Human Papillomavirus (HPV) Status in Tonsillar Cancer
- (2012) Anders Näsman et al. PLoS One
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immune Response During Therapy With Cisplatin or Radiation for Human Papillomavirus–Related Head and Neck Cancer
- (2009) William C. Spanos et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune Therapy for Cancer
- (2008) Michael Dougan et al. Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started